Diabetic retinopathy and the NMDA receptor

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Diabetic retinopathy is a major sight-threatening disease and is a leading cause of blindness. There is an emerging body of evidence that suggests that neuronal changes are an early phenomenon in the diabetic retina and that several cell types are affected, including the ganglion cells. The degeneration of these cells is thought to occur via overstimulation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor. Characteristic features of the normal mammalian retina and of the diabetic retina, and the involvement of NMDA receptors in diabetic retinopathy, are discussed.

Original languageEnglish (US)
Pages (from-to)226-232
Number of pages7
JournalDrug News and Perspectives
Volume15
Issue number4
DOIs
StatePublished - Jul 2 2002

Fingerprint

Diabetic Retinopathy
N-Methyl-D-Aspartate Receptors
Retina
Glutamate Receptors
N-Methylaspartate
Blindness
Ganglia

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Diabetic retinopathy and the NMDA receptor. / Smith, Sylvia B.

In: Drug News and Perspectives, Vol. 15, No. 4, 02.07.2002, p. 226-232.

Research output: Contribution to journalReview article

@article{7eb4003451ce49a0b40df368b232cbb6,
title = "Diabetic retinopathy and the NMDA receptor",
abstract = "Diabetic retinopathy is a major sight-threatening disease and is a leading cause of blindness. There is an emerging body of evidence that suggests that neuronal changes are an early phenomenon in the diabetic retina and that several cell types are affected, including the ganglion cells. The degeneration of these cells is thought to occur via overstimulation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor. Characteristic features of the normal mammalian retina and of the diabetic retina, and the involvement of NMDA receptors in diabetic retinopathy, are discussed.",
author = "Smith, {Sylvia B}",
year = "2002",
month = "7",
day = "2",
doi = "10.1358/dnp.2002.15.4.840055",
language = "English (US)",
volume = "15",
pages = "226--232",
journal = "Drug News and Perspectives",
issn = "0214-0934",
publisher = "Prous Science",
number = "4",

}

TY - JOUR

T1 - Diabetic retinopathy and the NMDA receptor

AU - Smith, Sylvia B

PY - 2002/7/2

Y1 - 2002/7/2

N2 - Diabetic retinopathy is a major sight-threatening disease and is a leading cause of blindness. There is an emerging body of evidence that suggests that neuronal changes are an early phenomenon in the diabetic retina and that several cell types are affected, including the ganglion cells. The degeneration of these cells is thought to occur via overstimulation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor. Characteristic features of the normal mammalian retina and of the diabetic retina, and the involvement of NMDA receptors in diabetic retinopathy, are discussed.

AB - Diabetic retinopathy is a major sight-threatening disease and is a leading cause of blindness. There is an emerging body of evidence that suggests that neuronal changes are an early phenomenon in the diabetic retina and that several cell types are affected, including the ganglion cells. The degeneration of these cells is thought to occur via overstimulation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor. Characteristic features of the normal mammalian retina and of the diabetic retina, and the involvement of NMDA receptors in diabetic retinopathy, are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0036087824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036087824&partnerID=8YFLogxK

U2 - 10.1358/dnp.2002.15.4.840055

DO - 10.1358/dnp.2002.15.4.840055

M3 - Review article

VL - 15

SP - 226

EP - 232

JO - Drug News and Perspectives

JF - Drug News and Perspectives

SN - 0214-0934

IS - 4

ER -